Keywords: Fear extinction; Exposure therapy; Augmented relearning; Reconsolidation; Drug development; Cognitive enhancer; 5-HT; 5-hydroxytryptamine = serotonin; AC; adenylate cyclase; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMY; amygdala; BA;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: aCSF; artificial cerebrospinal fluid; MDMA; 3,4-methylenedioxy-N-methylamphetamine; HEK; human embryonic kidney; ACMD; Advisory Council on the Misuse of Drugs; FCV; fast cyclic voltammetry; ANOVA; analysis of variance; DAT; dopamine transporter; NET; nora
Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay
Keywords: Dopamine transporter; Norepinephrine transporter; Serotonin transporter; Fluorescent monoamine substrate; Designer drugs; Drug screening; 2C-B; 2,5-dimethoxy-4-bromophenethylamine; 4-FA; 4-fluoroamphetamine; 5-APB; 5-(2-aminopropyl)benzofuran; 25B-NBOMe;
MALDI Orbitrap mass spectrometry for fast and simplified analysis of novel street and designer drugs
Keywords: MALDI; matrix-assisted laser desorption/ionization; HR; high-resolution; MS; mass spectrometry; HPLC; high performance liquid chromatography; UV-DAD; ultraviolet diode array detection; IMS; MALDI MS imaging; MS/MS; tandem mass spectrometry; ACN; acetonitr
Developing zebrafish models of autism spectrum disorder (ASD)
Keywords: ADHD; attention deficit hyperactivity disorder; ASD; autism spectrum disorder; AVP; arginine vasopressin; DSM-5; Dianostic and Statistical Manual of mental disorders, 5th edition; FXS; fragile X syndrome; GABA; gamma-aminobutyric acid; MDMA; 3,4-methylene
Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine and MDMA on morphine-induced amnesia
Keywords: 5-HT1A; 5-hydroxytryptamine 1A; ANOVA; analysis of variance; CeA; central amygdala; CPP; conditioned place preference; MDMA; 3,4-methylenedioxy-N-methylamphetamine; MORs; μ-opioid receptors; nACh; nicotinic acetylcholine; nAChRs; nicotinic acetylcholine
Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release
Keywords: Enzyme active site structure; Presynaptic inhibition; Exocytotic and non-exocytotic release; Neuroprotection; Parkinson's disease; Affective disorders; MAO; monoamine oxidase; MAO-A; monoamine oxidase isoform A; MAO-B; monoamine oxidase isoform B; COMT; c
Predicting CYP2C19 catalytic parameters for enantioselective oxidations using artificial neural networks and a chirality code
Keywords: CYP2C19; cytochrome P450 2C19; MDMA; 3,4-methylenedioxy-N-methylamphetamine; MDEA; 3,4-methylenedioxy-N-ethylamphetamine; MBDB; N-methyl-1,3-benzodioxolylbutanamine; BDB; 3,4-methylenedioxy-α-ethylphenethylamine; ANN; artificial neural network; HPLC; hig
Chronic and acute effects of 3,4-methylenedioxy-N-methylamphetamine ('ecstasy') administration on the dynorphinergic system in the rat brain
Keywords: opioids; dynorphin A; gene expression; abuse; amphetamine; CP; caudate putamen; CPP; conditioned place preference; CREB; c-AMP responsive element binding protein; DA; dopamine; DAT; dopamine transporter; DYN; dynorphin; HPA; hypothalamic-pituitary-adr